On Invalid Date, Soligenix (NASDAQ: SNGX) reported Q3 2023 earnings per share (EPS) of -$0.16, up 86.09% year over year. Total Soligenix earnings for the quarter were -$1.66 million. In the same quarter last year, Soligenix's earnings per share (EPS) was -$1.15.
As of Q4 2023, Soligenix's earnings has grown year over year. Soligenix's earnings in the past year totalled -$8.07 million.
What was SNGX's revenue last quarter?
On Invalid Date, Soligenix (NASDAQ: SNGX) reported Q3 2023 revenue of $130.44 thousand up 21.49% year over year. In the same quarter last year, Soligenix's revenue was $166.14 thousand.
What was SNGX's revenue growth in the past year?
As of Q4 2023, Soligenix's revenue has grown 11.9% year over year. This is 98.68 percentage points lower than the US Biotechnology industry revenue growth rate of 110.58%. Soligenix's revenue in the past year totalled $960.62 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.